Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,160.50 +153.26 1.18%
Hang Seng 20,944.90 -280.95 -1.32%
S&P/ASX 200 4,851.70 +37.35 0.78%
  • Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Avivagen Inc

+ Add to Watchlist

VIV:CN

0.0850 CAD 0.0050 5.56%

As of 15:58:42 ET on 06/18/2013.

Company Profile for Avivagen Inc (VIV)

Avivagen Inc. is a wellness company that is committed to developing and delivering products for animals and humans to assist in optimizing health and daily quality of life. The Company is advancing product candidates for the food animal market, companion animal market and various potential human applications.

Contact Information

Avivagen Inc

100 Sussex Drive
Ottawa, ON K1A 0R6
Canada
Phone: 1-613-990-0969
Fax: 1-613-993-0796

Key Executives for Avivagen Inc (VIV)

Jacques M BraultChairmanCameron GroomePresident/CEO
Chris BolandChief Financial OfficerJanusz DaroszewskiChief Scientific Officer/Secy

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil